Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ribas

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Cancer Research|December 26, 2001
CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cellsA Ribas, L H Butterfield, S N Amarnani, et al.
Cancer Research|April 29, 2000
Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in miceA Ribas, L H Butterfield, B Hu, et al.
BMC Genetics|December 24, 2013
Two new cytotypes reinforce that Micronycteris hirsuta Peters, 1869 does not represent a monotypic taxonTalita F A Ribas, Luis R R Rodrigues, Cleusa Y Nagamachi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirusL H Butterfield, S M Jilani, N G Chakraborty, et al.
Cancer Research|July 15, 1997
Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cellsA Ribas, L H Butterfield, W H McBride, et al.
Cancer Research|July 9, 1999
Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinomaC M Vollmer, F C Eilber, L H Butterfield, et al.
Journal of Visualized Experiments : Jove|December 15, 2025
Spatial Molecular Imaging of the Glycome Using Mass SpectrometryRoberto A Ribas, Franca Bucco Paolasso, Alison M Ryan, et al.
Cancer Research|September 15, 1999
p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinomaC M Vollmer, A Ribas, L H Butterfield, et al.
Archivos Espanoles De Urologia|June 1, 1996
[Preliminary results of a phase II randomized controlled trial comparing M-VAC and M-CAVI in patients with bladder cancer (T2-4 N0-1 M0)]J Bellmunt Molins, A Ribas, J Albanell, et al.
Cancer Research|December 5, 2000
Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cellsK J Andrews, A Ribas, L H Butterfield, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Cancer Research|December 26, 2001
CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cellsA Ribas, L H Butterfield, S N Amarnani, et al.
Cancer Research|April 29, 2000
Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in miceA Ribas, L H Butterfield, B Hu, et al.
BMC Genetics|December 24, 2013
Two new cytotypes reinforce that Micronycteris hirsuta Peters, 1869 does not represent a monotypic taxonTalita F A Ribas, Luis R R Rodrigues, Cleusa Y Nagamachi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirusL H Butterfield, S M Jilani, N G Chakraborty, et al.
Cancer Research|July 15, 1997
Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cellsA Ribas, L H Butterfield, W H McBride, et al.
Cancer Research|July 9, 1999
Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinomaC M Vollmer, F C Eilber, L H Butterfield, et al.
Journal of Visualized Experiments : Jove|December 15, 2025
Spatial Molecular Imaging of the Glycome Using Mass SpectrometryRoberto A Ribas, Franca Bucco Paolasso, Alison M Ryan, et al.
Cancer Research|September 15, 1999
p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinomaC M Vollmer, A Ribas, L H Butterfield, et al.
Archivos Espanoles De Urologia|June 1, 1996
[Preliminary results of a phase II randomized controlled trial comparing M-VAC and M-CAVI in patients with bladder cancer (T2-4 N0-1 M0)]J Bellmunt Molins, A Ribas, J Albanell, et al.
Cancer Research|December 5, 2000
Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cellsK J Andrews, A Ribas, L H Butterfield, et al.
Pageof 14